Oral Session 1-11D AML: Pathophysiology (2)

[OS1-11D-6] Analysis of GATA1 mutations in patients with myeloid leukemia of Down syndrome: JPLSG AML-D11 study

Kiminori Terui¹, Tsutomu Toki¹, Takashi Taga², Shotaro Iwamoto³, Takako Miyamura⁴, Daisuke Tomizawa⁵, Daisuke Hasegawa⁶, Hiroshi Moritake⁷, Asahito Hama⁸, Kentaro Nakashima⁹, Rika Kanezaki¹, Akiko Saito¹⁰, Keizo Horibe¹⁰, Souichi Adachi¹¹, Etsuro Ito¹ (1.Pediatrics, Hirosaki University, Hirosaki, Japan, 2.Pediatrics, Shiga University of Medical Science, Otsu, Japan, 3.Pediatrics, Mie University, Tsu, Japan, 4.Pediatrics, Osaka University, Osaka, Japan, 5.Children's Cancer Center, NCCHD, Tokyo, Japan, 6.Pediatrics, St Luke's International Hospital, Tokyo, Japan, 7.Pediatrics, University of Miyazaki, Miyazaki, Japan, 8.Pediatrics, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 9.Pediatrics, Kyushu University, Fukuoka, Japan, 10.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 11.Human Health Sciences, Kyoto University, Kyoto, Japan)